Title:
リマプロスト含有徐放性製剤
Document Type and Number:
Japanese Patent JP7383320
Kind Code:
B2
Abstract:
The present invention provides a sustained release formulation containing: at least one selected from the group consisting of limaprost and limaprost alfadex as an active ingredient; ethylcellulose as a sustained-release agent; hydroxypropyl betadex as a first stabilizer; and glyceryl behenate as a second stabilizer. A limaprost-containing sustained release formulation according to the present invention not only exhibits a sustained therapeutic effect by appropriately maintaining the drug concentration of limaprost even when administered twice a day, but can also increase the stability of limaprost.
More Like This:
Inventors:
Shin, Hyun-ik
John, Young Shik
Park, Ho Young
John, Young Shik
Park, Ho Young
Application Number:
JP2022571819A
Publication Date:
November 20, 2023
Filing Date:
May 21, 2021
Export Citation:
Assignee:
Youngsun Fine Chemical Company, Limited
International Classes:
A61K31/5575; A61K9/22; A61K47/14; A61K47/38; A61K47/40; A61P9/00; A61P43/00
Foreign References:
| KR1020180083239A | ||||
| KR1020140029467A | ||||
| KR1020150138104A | ||||
| KR1020120007662A | ||||
| CN106822013A |
Attorney, Agent or Firm:
HARAKENZO WORLD PATENT & TRADEMARK
Previous Patent: bipolar mapping suction device
Next Patent: Battery deterioration level determination system
Next Patent: Battery deterioration level determination system